BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vijayakumar EC, Bhatt LK, Prabhavalkar KS. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics. Curr Drug Targets 2019;20:1474-85. [PMID: 31215389 DOI: 10.2174/1389450120666190618125100] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu X, Liu L, Wang Y, Cong J, Lin Z, Wang Y, Liu Q, Wang L, Yang B, Li T. lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. Front Oncol 2021;11:651693. [PMID: 34094941 DOI: 10.3389/fonc.2021.651693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liu L, Zhang J, Zhang X, Cheng P, Liu L, Huang Q, Liu H, Ren S, Wei P, Wang C, Dou C, Chen L, Liu X, Zhang H, Chen M. HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target. J Mol Med (Berl) 2021;99:107-18. [PMID: 33128580 DOI: 10.1007/s00109-020-01998-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sun G, Shen JF, Wei XF, Qi GX. Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction. J Inflamm Res 2021;14:6397-407. [PMID: 34880642 DOI: 10.2147/JIR.S339133] [Reference Citation Analysis]
4 Yang X, Zhang X, Ma Y, Wang Z, Huang K, Liu G, Shen K, Zhu G, Wang T, Lv S, Zhang C, Yang H, Liu S. Abnormal Rat Cortical Development Induced by Ventricular Injection of rHMGB1 Mimics the Pathophysiology of Human Cortical Dysplasia. Front Cell Dev Biol 2021;9:634405. [PMID: 33748118 DOI: 10.3389/fcell.2021.634405] [Reference Citation Analysis]
5 Tanaka F, Uda M, Hirose Y, Hirai Y. Restoration of calcium-induced differentiation potential and tight junction formation in HaCaT keratinocytes by functional attenuation of overexpressed high mobility group box-1 protein. Cytotechnology 2020;72:165-74. [PMID: 31916113 DOI: 10.1007/s10616-019-00367-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Behl T, Sharma E, Sehgal A, Kaur I, Kumar A, Arora R, Pal G, Kakkar M, Kumar R, Bungau S. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs. Mol Biol Rep 2021;48:1869-81. [PMID: 33479829 DOI: 10.1007/s11033-020-06130-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vergoten G, Bailly C. Analysis of glycyrrhizin binding to protein HMGB1. Medicine in Drug Discovery 2020;7:100058. [DOI: 10.1016/j.medidd.2020.100058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wang S, Guan YG, Zhu YH, Wang MZ. Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective. World J Psychiatry 2022; 12(6): 779-786 [DOI: 10.5498/wjp.v12.i6.779] [Reference Citation Analysis]
9 Abdelmageed ME, Nader MA, Zaghloul MS. Targeting HMGB1/TLR4/NF-κB signaling pathway by protocatechuic acid protects against l-arginine induced acute pancreatitis and multiple organs injury in rats. Eur J Pharmacol 2021;906:174279. [PMID: 34197778 DOI: 10.1016/j.ejphar.2021.174279] [Reference Citation Analysis]
10 Chou YE, Yang PJ, Lin CY, Chen YY, Chiang WL, Lin PX, Huang ZY, Huang M, Ho YC, Yang SF. The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics. Int J Environ Res Public Health 2020;17:E7247. [PMID: 33023053 DOI: 10.3390/ijerph17197247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Merlo S, Spampinato SF, Caruso GI, Sortino MA. The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention. Curr Neuropharmacol 2020;18:446-55. [PMID: 32003695 DOI: 10.2174/1570159X18666200131105418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yan X, Xu P, Zhou L, Lu J, Tang H, Zheng Y, Cao H. Blockade of high mobility group box 1 involved in the protective of curcumin on myocardial injury in diabetes in vivo and in vitro. IUBMB Life 2020;72:931-41. [DOI: 10.1002/iub.2226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Jiang J, Hu B, Chung CS, Chen Y, Zhang Y, Tindal EW, Li J, Ayala A. SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model. Mol Med 2020;26:89. [PMID: 32957908 DOI: 10.1186/s10020-020-00210-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Xiao Y, Ding L, Yin S, Huang Z, Zhang L, Mei W, Wu P, Wang P, Pan K. Relationship between the pyroptosis of fibroblast‑like synoviocytes and HMGB1 secretion in knee osteoarthritis. Mol Med Rep 2021;23:97. [PMID: 33300062 DOI: 10.3892/mmr.2020.11736] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kianian F, Kadkhodaee M, Sadeghipour HR, Karimian SM, Seifi B. An overview of high-mobility group box 1, a potent pro-inflammatory cytokine in asthma. J Basic Clin Physiol Pharmacol 2020;31. [PMID: 32651983 DOI: 10.1515/jbcpp-2019-0363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rico-Díaz A, Barreiro-Alonso A, Rey-Souto C, Becerra M, Lamas-Maceiras M, Cerdán ME, Vizoso-Vázquez Á. The HMGB Protein KlIxr1, a DNA Binding Regulator of Kluyveromyces lactis Gene Expression Involved in Oxidative Metabolism, Growth, and dNTP Synthesis. Biomolecules 2021;11:1392. [PMID: 34572607 DOI: 10.3390/biom11091392] [Reference Citation Analysis]
17 Biscetti F, Rando MM, Nardella E, Cecchini AL, Pecorini G, Landolfi R, Flex A. High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives. Int J Mol Sci. 2019;20. [PMID: 31835864 DOI: 10.3390/ijms20246258] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
18 Li L, Liu H, Tao W, Wen S, Fu X, Yu S. Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting. Front Pharmacol 2021;12:731386. [PMID: 34867338 DOI: 10.3389/fphar.2021.731386] [Reference Citation Analysis]
19 Ciprandi G, Bellussi LM, Passali GC, Damiani V, Passali D. HMGB1 in nasal inflammatory diseases: a reappraisal 30 years after its discovery. Expert Review of Clinical Immunology 2020;16:457-63. [DOI: 10.1080/1744666x.2020.1752668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Land WG. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution. Mol Diagn Ther 2020;24:251-62. [PMID: 32248387 DOI: 10.1007/s40291-020-00460-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
21 Chen L, Li J, Ye Z, Sun B, Wang L, Chen Y, Han J, Yu M, Wang Y, Zhou Q, Seidler U, Tian D, Xiao F. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice. Front Immunol 2020;11:585094. [PMID: 33193406 DOI: 10.3389/fimmu.2020.585094] [Reference Citation Analysis]
22 Moriyama K, Nishida O. Targeting Cytokines, Pathogen-Associated Molecular Patterns, and Damage-Associated Molecular Patterns in Sepsis via Blood Purification. Int J Mol Sci 2021;22:8882. [PMID: 34445610 DOI: 10.3390/ijms22168882] [Reference Citation Analysis]
23 Deng LC, Alinejad T, Bellusci S, Zhang JS. Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion. Front Pharmacol 2020;11:426. [PMID: 32322205 DOI: 10.3389/fphar.2020.00426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Tu P, Tian R, Lu Y, Zhang Y, Zhu H, Ling L, Li H, Chen D. Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus. Chin Med 2020;15:128. [PMID: 33349263 DOI: 10.1186/s13020-020-00415-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Yang Z, Simovic MO, Edsall PR, Liu B, Cancio TS, Batchinsky AI, Cancio LC, Li Y. HMGB1 Inhibition to Ameliorate Organ Failure and Increase Survival in Trauma. Biomolecules 2022;12:101. [DOI: 10.3390/biom12010101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Baeeri M, Didari T, Khalid M, Mohammadi-Nejad S, Daghighi SM, Farhadi R, Rahimifard M, Bayrami Z, Haghi-Aminjan H, Foroumadi R, Gholami M, Abdollahi M. Molecular Evidence of the Inhibitory Potential of Melatonin against NaAsO2-Induced Aging in Male Rats. Molecules 2021;26:6603. [PMID: 34771016 DOI: 10.3390/molecules26216603] [Reference Citation Analysis]
27 Zhu X, Huang H, Zhao L. PAMPs and DAMPs as the Bridge Between Periodontitis and Atherosclerosis: The Potential Therapeutic Targets. Front Cell Dev Biol 2022;10:856118. [DOI: 10.3389/fcell.2022.856118] [Reference Citation Analysis]